Qisda Corporation · TWSE:2352

Qisda — Q2 2023 Earnings Presentation

27 slides from Qisda's earnings presentation, Aug 7, 2023

  1. Slide 1: Qisda Corporation Investor Conference: 2023 Q2 Results

    Qisda Corporation Investor Conference: 2023 Q2 Results August 7, 2023 1

  2. Slide 2: Participants

    Participants Chairman Peter Chen President Joe Huang CFO Jasmin Hung GM, Information Technology Business Group Daniel Hsueh GM, Commercial and Industrial Business Group Yuchin Lin GM, Medical Devices Business Group Harry Yang GM, Business Solutions Group Michael Lee GM, Networking and Communication

  3. Slide 3: Agenda

    Agenda 1. Company Profile CFO Jasmin Hung 2. 2023 Q2 Financial Results Chairman Peter Chen 3. Business Update and Outlook President Joe Huang GM of each Business Group 4. Q&A 3

  4. Slide 4: Safe Harbor Notice

    Safe Harbor Notice We have made forward-looking statements in the presentation. Our forward- looking statements contain information regarding, among other things, our financial conditions, future expansion plans and business strategies. We have based these forward-looking statements on our current e

  5. Slide 5: 1. Company Profile

    1. Company Profile CFO Jasmin Hung 5

  6. Slide 6: Qisda Group

    Qisda Group Qisda is a global technology group with businesses spanning information technology, medical, smart business solutions, and networking communication. Global Presence 2023 1H Revenue Year Established 1984 NTD $103B (USD$ 3.4B) IPO Year 1996 Manufacturing Sites:Taiwan, China, (Ticker 2352)

  7. Slide 7: Business Groups Qisda Group

    Business Groups Qisda Group (till 2023Q2) IT MEDICAL BSG NCG OTHERS Information Technology Business Solutions Networking & Communication (43% + 8%) (12%) (16%) (15%) (6%) Revenue (NTD) 52.8 B 11.8 B 16.3 B 15.6 B 6.1 B ➢ Displays 33.8 B ➢ Medical Services ➢ IT Intelligence Partner ➢ LAN/MAN ➢ Materi

  8. Slide 8: 2. 2023 Q2 Financial Results

    2. 2023 Q2 Financial Results CFO Jasmin Hung 8

  9. Slide 9: 2023 Q2 Highlights

    2023 Q2 Highlights ◆ Q2 revenue, operating income amount, net profit attributable to Qisda and EPS grew QoQ. • GM% and OI% risen for three consecutive quarters. GM% reached 16.3%, surpassing 16% and highest in 20 years on quarterly basis. • Net profit attributable to Qisda and EPS increased QoQ and

  10. Slide 10: Consolidated Statement of Comprehensive Income (Quarterly)

    Consolidated Statement of Comprehensive Income (Quarterly) Unit : NT$ Million YoY QoQ 2023 Q2 2022 Q2 2023 Q1 amt g% amt g% Net Sales 52,112 100% 62,794 100% (10,683) -17% 50,446 100% 1,666 3% Cost of Goods Sold (43,615) (53,521) 9,906 (42,451) (1,164) Gross Margin 8,497 16.3% 9,273 14.8% (776) -8%

  11. Slide 11: Consolidated Statement of Comprehensive Income (First Half)

    Consolidated Statement of Comprehensive Income (First Half) Unit : NT$ Million YoY 2023 1H 2022 1H amt g% Net Sales 102,557 100% 123,660 100% (21,103) -17% Cost of Goods Sold (86,065) (106,514) 20,448 Gross Margin 16,492 16.1% 17,146 13.9% (654) -4% Operating Expenses (13,699) -13.4% (13,559) -11.0%

  12. Slide 12: Consolidated Balance Sheet Highlights

    Consolidated Balance Sheet Highlights Unit : NT$ Million QoQ YoY 2023.06.30 2023.03.31 2022.06.30 amt g% amt g% Cash & Equivalent 27,174 14% 36,052 18% (8,877) -25% 18,550 9% 8,624 46% Accounts Receivable 38,007 20% 37,472 18% 535 1% 43,110 21% (5,102) -12% Inventory 35,845 19% 39,656 19% (3,811) -1

  13. Slide 13: Financial Ratios

    Financial Ratios 2023.06.30 2023.03.31 QoQ 2022.06.30 YoY AR Turnover (Days) 74 75 -1 76 -2 Inventory Turnover (Days) 85 90 -5 91 -6 AP Turnover (Days) 62 61 +1 70 -8 Cash Conversion Cycle (Days) 97 104 -7 97 +0 Current ratio 132% 136% -4 ppt 121% +11 ppt 13

  14. Slide 14: Financial Trend – Quarterly Trend

    Financial Trend – Quarterly Trend • Revenue: NTD 52.1B (QoQ up by 1.7B, +3ppt). • GM% and OI% risen for three consecutive quarters: GM% reached 16.3%, surpassing 16%, highest in 20 years on quarterly basis. NT$ 100M Revenue NT$ 100M Operating Income (OI) 1,000 40 g% -2% 3% -4% -7% -10% 3% g% -25% 71

  15. Slide 15: Financial Trend – Q2 YOY

    Financial Trend – Q2 YOY • 1H results: GM% was 16.1%(YoY +2.2ppt), highest in 20 years on half-year basis. NT$ 100M Revenue NT$ 100M Operating Income (OI) 1,000 40 g% 16% 8% 6% 28% 12% -17% g% 37% 28% -16% 33% 19% -36% 500 20 560 628 22.6 521 19.1 381 412 437 17.0 13.3 14.3 14.4 0 0 Q2'18 Q2'19 Q2'2

  16. Slide 16: Business Group Trend – Quarterly Trend

    Business Group Trend – Quarterly Trend High-value added (HVA) Medical BSG NT$ 100M NT $ 100M NT$ 100M g% -2% 9% 7% 0% -7% 2% g% -4.1% 15% 7% 1% 4% 7% g% -7% 1% 6% 2% -3% 1% 300 100 100 250 80 80 200 60 60 150 263 281 280 264 241 260 40 40 82 83 81 82 76 77 100 55 55 57 61 44 51 20 20 50 0 0 0 Q1'22

  17. Slide 17: Financial highlights by Business Group – Q2

    Financial highlights by Business Group – Q2 NT$ 100M 2023 Q2 YoY QoQ Business Group Revenue Revenue Revenue GM% Revenue GM% Revenue GM% Revenue Growth Growth Portion Range Amount Range Amount Range Rate Rate Medical 12% 61 20-25 +10 +20% unchanged +4 +7% unchanged BSG 16% 82 15-20 +5 +6% unchanged +

  18. Slide 18: Revenue Breakdown by Business (Quarterly)

    Revenue Breakdown by Business (Quarterly) 100% Materials 6% 6% 6% 6% 5% 6% 6% and Others 10% 11% 13% NCG 15% 16% 16% 15% 80% BSG 13% 13% 12% 14% 15% 16% 7% 16% 51% Medical 7% 8% 60% 9% 9% 10% IT_HVA 9% 8% 12% 11% 5% 5% 9% 6% 9% IT_Other 6% 5% 8% 8% 5% 7% 5% 40% 5% 5% Projector 6% 7% 5% 6% Monitor 20

  19. Slide 19: High Value-added Revenue Portion Trend

    High Value-added Revenue Portion Trend • Q2 high value-added businesses revenue accounts for 51%. % Quarterly Yearly 60% 60% 50% 51% 51% 51% 50% 47% 50% 45% 8% 8% 41% 8% 40% 41% 9% 9% 40% 40% 34% 9% 9% 8% 16% 15% 9% 15% 16% 30% 15% 30% 6% 14% 11% 13% 22% 12% 18% 9% 20% 16% 16% 20% 6% 16% 14% 15% 12%

  20. Slide 20: Qisda Group’s Listed Companies Results (YoY)

    Qisda Group’s Listed Companies Results (YoY) 2023 1H 2022 1H YoY Differences Revenue Net Income* EPS Revenue Net Income* EPS Revenue Net Income* EPS Business Group Company YoY% YoY% (NTD Million) (NTD Million) (NTD) (NTD Million) (NTD Million) (NTD) (NTD Million) (NTD Million) (NTD) DataImage (ROTC)

  21. Slide 21: 3. Business Update and Outlook

    3. Business Update and Outlook Chairman Peter Chen President Joe Huang GM of each Business Group 21

  22. Slide 22: 2023 Q3 Outlook

    2023 Q3 Outlook ◆ Respond Prudently to Global Economic Uncertainties • Factors such as inflation, regional wars, rising interest rates, bank risks and slowing market demand bring challenges to operations, which require extra attention. • Market supply and demand has gradually restored but is yet to

  23. Slide 23: Organization Optimization & Synergy Enhancement

    Organization Optimization & Synergy Enhancement BenQ Medical Tech acquires 40% stake in K2 Medical from Qisda BenQ Medical Tech Optimizing the structure of medical business to accelerate synergy enhancement 2023/8/4 Approved Medical acquires and strengthen competitiveness in group’s medical devices.

  24. Slide 24: Qisda ESG Awards and Recognition

    Qisda ESG Awards and Recognition Qisda Group commits in expand influence in sustainability, 6 companies totally won 13 Sustainability Awards in 1H,2023 AREA Investment in People Category Qisda HR Asia BenQ Best Companies to Work For in Asia for 5 years Materials TSAA SDG02-Silver Award “Social Inclu

  25. Slide 25: 2023 Strategic Directions

    2023 Strategic Directions IT Medical • China+1 strategy and increase production scale in Vietnam • Medical devices and pharmaceuticals as dual growth • In-depth development in high-end monitors, prepared for engines to expand in distribution channels market recovery • In-depth development in dialysi

  26. Slide 26: . © Qisda Corporation, all rights reserved.

    26 confidential. © Qisda Corporation, all rights reserved. Qisda

  27. Slide 27: Value-Up Solutions

    27 Contents 16 Giada Cp Oisda Value-Up Solutions Qisda

Qisda — Q2 2023 Earnings Presentation on 6ix